Mutations of the PALB2 tumor suppressor gene in humans are associated with hereditary predisposition to breast and also some other cancers. In the present study, we have characterized mice deficient in Palb2. The data show that the Palb2
INTRODUCTION
Tumor suppressor genes encode proteins that are negative regulators of cell proliferation by being involved in cell division and apoptosis, and are also often essential for the activation of repair after DNA damage. Loss of function mutations in tumor suppressors release the cells from normal growth restraint and cause uncontrolled cell proliferation, promoting the development of malignancies (1 -3) . Germline mutations in tumor suppressors such as BRCA1 (breast cancer gene 1) and BRCA2 (breast cancer gene 2) are associated with an inherited predisposition to breast cancer, and inactivation mutations of these genes in mice cause abnormalities in cellular proliferation and differentiation, and in embryonic development (1, 3) . PALB2 (partner and localizer of BRCA2) was originally identified as a BRCA2-interacting protein and it plays an important role in the regulation of the activity and intracellular localization of BRCA2. In response to DNA damage, PALB2 localizes to chromatin at the site of the lesion where it assembles as oligomers, which then serve as an anchor for BRCA2. The PALB2 -BRCA2 interaction is vital for the proper function of BRCA2 in the homologous recombination (HR)-based DNA double-strand break repair and in the intra-S phase checkpoint control functions of BRCA2. Accordingly, disruption of PALB2 -BRCA2 interaction results in defective HR, and increases cellular sensitivity to DNA damaging agents (4, 5) . Recently, an interaction between PALB2 and BRCA1 was also reported. Importantly, PALB2 mediates the communication between BRCA1 and † Equal contribution. * To whom correspondence should be addressed. Tel: +358 83153228; Fax: +358 83156354; Email: robert.winqvist@oulu.fi # The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org Human Molecular Genetics, 2010, Vol. 19, No. 15 3021-3029 doi:10.1093/hmg/ddq207 Advance Access published on May 18, 2010 BRCA2 by directly associating with BRCA1, and the PALB2 -BRCA1 interplay is also critical for HR (6, 7) .
Similarly to BRCA1, defects in the PALB2 tumor suppressor gene are associated with hereditary predisposition to breast cancer. Studies on the role of PALB2 mutations in breast cancer susceptibility have been conducted in several Caucasian and Asian populations, and the results have indicated a 2-6-fold increased risk for the mutation carriers (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . In our previous study, we identified a relatively common Finnish PALB2 1592delT founder mutation, the carriers of which are estimated to be at a 40% risk for developing breast cancer by the age of 70 years (15) . In addition, PALB2 has been suggested to be involved in some other cancer types as well (10, 19) .
Analogous to BRCA2, PALB2 is a Fanconi anemia (FA) associated gene also known as FANCN (8, 20, 21) . FA is a rare autosomal or an X-linked recessive disease characterized by developmental abnormalities, progressive bone marrow failure and cancer susceptibility (22) . Biallelic inactivating mutations in PALB2 cause the disease subtype FA-N. Most of the mutations observed in this type of FA are frameshifts leading to a truncated protein product and are though to be effectively null (8) , although the hypomorphic nature of these alleles cannot be totally excluded. FA-N resembles the FA-D1 phenotype caused by biallelic mutations in BRCA2, where the affected children display typical features of FA and cellular hypersensitivity to DNA cross-linking agents. Interestingly, FA caused by biallelic mutations in BRCA2 or PALB2 has a more severe clinical phenotype than other types of FA, with higher risks of leukemia and brain tumors (8, 21, 23) .
The biological and physiological consequences of BRCA1 and BRCA2 defects in humans have been extensively assessed by modeling in mouse. Brca1-and Brca2-deficient mice display very similar phenotypes, including early embryonic lethality and decreased cell proliferation. Thus, studies in vivo have shown that both Brca1 and Brca2 are necessary for normal embryogenesis in mice (1, 3) . In the present study, we have generated a mouse model lacking a functional Palb2 gene. Mice heterozygous (HE) for the insertion of a gene trap construct inactivating Palb2 (Palb2 (+/2) ) were viable, phenotypically normal and fertile, whereas HO inactivation of the gene (Palb2 (2/2) ) results in an embryonic lethal phenotype. Thus, the current analysis of Palb2 HO knockout embryos in vivo and in vitro demonstrates that Palb2 plays a critical role in early embryonal development, similarly to Brca1 and Brca2.
RESULTS

Analysis of Palb2 expression during early fetal development in mice
An embryonic stem (ES) cell line [CG0691, Sanger Institute Gene Trap Resource (SIGTR) database (http://www.sanger.ac. uk)] containing a gene trap vector inserted into the Palb2 gene on mouse chromosome 7 (Fig. 1A ) was used to produce mice deficient in Palb2 expression. The insertion of the gene trap vector leads to a transcript consisting of the first exon of the Palb2 fused with a Lac-Z reporter gene (Fig. 1B) . The 5 ′ -RACE analysis of the fusion transcript further confirmed that the gene trap vector had integrated in the first intron of Palb2. The absence of Palb2 expression in the Palb2 (2/2) mice was confirmed by using quantitative RT-PCR (Fig. 2) . The expression of Palb2 in HO knockout mice (harboring only the mutant allele construct Palb2 Ex1-bgeo) was visualized by using X-Gal staining. The data indicated that Palb2 was broadly expressed in the mouse embryo, and high levels of expression were detected as early as at embryonic day 7.5 (E7.5) in the primitive streak (Fig. 1C, upper panel) . At E8.5, Palb2 expression was observed in the open neural folds both at the anterior and posterior regions of the body, and the expression was ubiquitous (Fig. 1C, lower panel) .
Palb2 mutation results in embryonic lethality
Mice HE for the Palb2 gene trap insertion (Palb2 +/2 ) were viable, phenotypically normal and fertile. To address whether the loss of one Palb2 allele would lead to increased frequency of spontaneous tumors, HE mice were followed up till the age of 8 months, but no macroscopic tumors were observed in any of the organs analyzed (mammary, kidney, heart, adrenals, lungs, liver, intestinal, spleen, brain, ovary, testis, epididymis and prostate). However, we cannot, at this point, completely rule out the slight possibility that the HE Palb2 (+/2) mice might still eventually develop some tumors at a more advanced age. For this reason, HE mice will be followed up until they are at least 2 years old. No viable Palb2 (2/2) mice were identified among the 200 pups genotyped at the age of 2 weeks from HE matings. This indicated that in mice the HO inactivation of Palb2 results in embryonic lethality. To assess the consequences of the loss of Palb2 on embryonic development, embryos from HE intercrosses were analyzed at different stages of gestation. At E7.5, Palb2 (2/2) embryos were detected at the expected Mendelian frequency. However, resorptions and empty conceptues were observed from this stage onward. No live Palb2 (2/2) mouse embryos were observed beyond E9.5. This is also evident from the observed significant deviation from the expected Hardy -Weinberg genotype distribution analyzed at birth (P ¼ 0.006 for E9.5 and E11.5 embryos and P ¼ 9.41 e 214 for postnatal mice, Table 1 ). In addition, several attempts were made to generate Palb2 (2/2) ES cell lines, but all of them proved unsuccessful (data not shown).
Palb2 mutation results in morphological and histological abnormalities
The morphology of the Palb2 (2/2) embryos was already distinguishable from the wild-type (WT) and Palb2 (+/2) littermates at E6.5 (data not shown) and the histological analysis revealed that the Palb2 (2/2) null embryos were markedly smaller in size than their WT littermates ( Fig. 3A-C) , even though the two-layer structure of ectodermal and endodermal cells enclosing the proamniotic cavity was readily identified in some of the knockout embryos ( Fig. 3B and C) . By E7.5, the difference in size between WT and Palb2 (2/2) embryos was even more obvious. In whole mount analysis of the null embryos, only a poorly defined boundary between the embryonic and extra embryonic regions was observed, in contrast to the proper ectoplacental cone, primitive streak and head fold present in the WT embryos ( Fig. 4A and B analysis of WT embryos revealed a well-defined anterior -posterior axis with a proper formation of the epiblast and the typical structures for the mesodermal layer, ectoplacental cone, chorion and amnion ( Fig. 3D ) and the embryos had initiated gastrulation, indicated by a formation of the primitive streak. However, the embryonic ectoderm of the Palb2
embryos appeared with an increased mass of cells and the embryonic cavities were not properly formed. In addition, the amnion of the Palb2 (2/2) embryos was undetectable ( Fig. 3E and F) . At E8.5, the Palb2 (2/2) embryos showed normal extra embryonic structures ( Fig. 4C and D) , while the difference in size between the WT and Palb2 (2/2) embryos was further increased ( Fig. 4E and F) . The Palb2 (2/2) embryos had developed a head fold and a neural groove, the mesoderm formation and patterning was initiated, as indicated by Lim1 expression, being a marker for intermediate mesoderm, primitive streak-derived tissues and extra embryonic tissues for head formation. However, the mesoderm failed to differentiate properly as the somite structures never formed (Fig. 5 ). Analyzing sonic hedgehog (Shh) expression revealed a notochord with diffuse and discontinuous morphology (Fig. 5) . Furthermore, lack of proper Brachyury expression (data not shown) revealed that the Palb2 (2/2) embryos lacked proper tail-bud structures, and the notochord did not progress caudally. At E9.5, the Palb2 (2/2) embryos had not significantly progressed in their development of that observed at E8.5 ( Fig. 4G and H) , and the Palb2 embryos did not show proper organogenesis (Fig. 4I and J) . In addition, most of the mutant embryos were reabsorbed, or were undergoing degeneration within the yolk sac ( Table 1) .
Disruption of Palb2 in mouse decreases embryonic growth in vitro and in vivo
The Palb2 (2/2) blastocysts showed a normal appearance, indicating that the lack of functional Palb2 protein does not affect the pre-implantation stage of development ( Fig. 6A and B) . However, 85% of the mutant blastocysts presented with impaired outgrowth of the inner cell mass (ICM) in vitro, while only 25% of ICM of the WT and HE blastocysts failed to grow (Fig. 6C-F) . This was in contrast to the trophoblastoid giant cells that developed normally in the cultured Palb2 (2/2) embryos ( Fig. 6D and F) . These results are consistent with the growth retardation observed in the mutant embryos in vivo.
Expression of p21 is increased in Palb2 mutant embryos
Quantitative RT-PCR analysis was used to confirm the lack of Palb2 mRNA in the Palb2 (2/2) embryos (Fig. 2) , and the level of Brca1, Brca2, Rad51, p53, p27 and p21 expression was also determined. No difference was observed between the Palb2 (2/2) and WT embryos in their expression of Brca1, Brca2 or Rad51 (data not shown). However, the reduced growth of the Palb2 (2/2) embryos were associated with a 6-fold increased expression of p21 (P ¼ 0.002), while the levels of p53 (P ¼ 0.435) and p27 (P ¼ 1.000) mRNAs were not altered in Palb2 (2/2) embryos when compared with the WT littermates (Fig. 2) .
DISCUSSION
Studies have indicated that PALB2 interacts with both BRCA1 and BRCA2 in vitro, and has a crucial role on their DNA damage response functions (5 -7). Previous studies have also shown that BRCA1 and BRCA2 have indispensable roles in early mouse embryogenesis, and Brca1 and Brca2 deficiency has been showed to cause embryonic lethality in mice (1, 3, 24, 25) . Identically, in the present study, the Palb2 deficient mouse embryos were found to be abnormal as early as at E6.5, and by E7.5 all embryos were developmentally retarded, although they had initiated gastrulation before dying at around E9. 5 
Our inability to generate ES cells deficient in Palb2, together with the abundant Palb2 expression in the primitive streak already evident at E7.5, suggest that Palb2 is essential for cell proliferation during embryogenesis in rapidly dividing cells. In addition, at E8.5, Palb2 was found to be broadly expressed in the entire embryo, but was particularly high in the open neural folds at both the anterior and posterior regions of the embryo, in accordance with an increased cell proliferation at these regions. The essential role for Palb2 in cell proliferation is also supported by our studies in vitro showing that at E3.5 the Palb2 (2/2) blastocysts appeared normal, but their ICM did not proliferate normally. Similarly to that shown for Brca2 mutant blastocysts, a growth defect was observed in Palb2 (2/2) blastocyst culturing. Thus, it appears that neither Palb2, Brca2, nor Brca1 deficient embryos are capable of growing in vitro.
Gastrulation in the mouse embryo takes place at around E6.5, upon which the mesoderm is formed from the epiblast. In this process, the volume of the embryonic tissue increases up to 40-fold, largely due to the expansion of the tissue giving rise to the extra embryonic ectoderm. Accordingly, between E5.5 and E7.5, the cell number in the embryo increases by over 100-fold (27, 28) . Palb2 (2/2) mouse embryos initiate gastrulation at E7.5, but the proper formation of embryonic cavities is disrupted and the amnion is missing. These defects are also observed in Brca1 and Brca2 mutant embryos (1,3) and a reduced size is the shared feature of Brca1, Brca2 and Palb2 deficient embryos. However, while the differentiation of Brca1 and Brca2 stops at gastrulation, Palb2 (2/2) mutant embryos show neural plate and neural groove development. Furthermore, by E8.5, also neural folds were formed in the Palb2 (2/2) embryos, but the more posterior structures never form a proper neural tube. Thus the Palb2 deficient embryos develop to a slightly more advanced stage when compared with the Brca1 and Brca2 deficient mice. Accordingly, shh expression revealed the formation of notochordal process in the Palb2 (2/2) embryos, but the Figure 2 . Expression of p21, p53, p27 and Palb2 in Palb2 (2/2) embryos at E8.5. The expression levels of p21, p53, p27 and Palb2 were analyzed from E8.5 wild-type (WT) and Palb2 (2/2) (HO) embryos using quantitative RT-PCR. The expression of p21 was markedly increased in the E8.5 Palb2 embryos indicates that the Palb2 knockout had been successfully carried out. The levels of p53 (P ¼ 0.435) and p27 (P ¼ 1.000) mRNAs were not altered in the E8.5 Palb2 (2/2) embryos. Quantitative RT-PCR data were normalized to the expression of mouse Ppia gene. n ¼ 2-3 pools, each consisting of 4 -6 embryos. NS, not significant; ND, not determined.
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Human Molecular Genetics, 2010, Vol. 19, No. 15 notochordal mesoderm remained diffuse and showed interrupted pattern and failure to form a proper notochord from the pre-chordal plate more posteriorly. A similar discontinuous notochordal structure has been observed in a5 integrin-null embryos, the development of which, however, progresses somewhat further but results in severe posterior dysgenesis (29) . In Palb2 (2/2) embryos, the most cranial structures are formed but the paraxial mesoderm remains undifferentiated as indicated by the lack of somite formation in the embryos. On the other hand, a proper Lim1 expression at E7.5 suggested that both the paraxial and intermediate mesoderm form in the growth retarded embryos, but thereafter the differentiation is either deceased or severely delayed. We could not detect any epithelialization of the paraxial mesoderm, nor was heart The embryos were collected on days 7.5, 8.5, 9.5 and 11.5 of pregnancy from Palb2 heterozygous intercrosses. The genotypes were determined by PCR using DNA extracted from the yolk sac of E7.5-E11.5 embryos, or earmarks of postnatal mice. Resorptions were not subjected to genotypic analysis and were therefore not accounted for in the HWE analysis. E, embryonic day; HWE, Hardy-Weinberg equilibrium. (2/2) embryos at E7.5. Only the ectoplacental cavity was detectable, and the cell mass was increased in the amniotic cavity region (arrow in E). (F) The histological appearance of the Palb2 (2/2) embryos at E7.5 was variable, while some of the embryos lacked almost all normal histological structures. ac, amniotic cavity; am, amnion; ex, exocoelomic cavity; ch, chorion; epc, ectoplacental cavity; ep, ectoplacental cone; ec, ectoderm; me, mesoderm; en, endoderm; ven, visceral endoderm. Bars 100 mm.
formation observed in the mutant embryos which speaks further for a failure in mesodermal organogenesis. Therefore, the phenotype observed in Palb2 (2/2) embryos cannot be explained solely based on lack of the proliferation boost after gastrulation, but there is also a failure in the differentiation of (2/2) embryos at E9.5 were encased in a spherical structure formed by the yolk sac and the amnion, and completely voided of normal morphology.
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Human Molecular Genetics, 2010, Vol. 19, No. 15 mesoderm-derived structures, which is essential for the further embryonal development. p21 is a checkpoint inhibitor protein regulating cell cycle progression at G1 and is also known to be regulated by the tumor suppressor protein p53 (30) . Overexpression of p21 has been shown to inhibit proliferation of mammalian cells, and to inhibit all Cyclin-CDK complexes (31) . Interestingly, mouse Palb2 deficiency caused an increase in the expression of p21 (P ¼ 0.002), while the expression of p53 was unaffected. These results suggest that other regulatory signals downstream of Palb2, than those mediated through p53, are responsible for the increased p21 levels observed in Palb2 (2/2) embryos. Increased p21 expression has also been observed in Brca1 and Brca2 deficient mice, further supporting our conclusion that mouse Palb2 deficiency causes a significant defect in embryonic cell proliferation (3, 32, 33) .
Recent studies in humans have shown that inactivating mutations in PALB2 lead to a compromised DNA damage response and defective cross-link repair, and therefore, predispose HE carriers to breast cancer (10) . In addition, different biallelic loss-of-function mutations in FA patients have been reported and these are mainly thought to result in null alleles. However, all the FA-N patients reported so far are compound heterozygotes for the presumable null mutations, some of which that could in fact prove to be hypomorphic mutations (8, 21) .
Here, we have shown that the Palb2 gene plays an important role in early mouse embryogenesis, and demonstrate that the PALB2 protein is essential for cell proliferation. We have also provided evidence supporting the requirement of Palb2 for the cell cycle progression in early embryonic cells. Indeed, Palb2 seems to be indispensible for early embryonic development in mice. Defective Palb2 function during early embryonic development results in insufficient cell proliferation, which might originate from the accumulation of a lethal amount of DNA damage, and in a mesoderm differentiation failure. Together these problems occurring at such an early embryonal developmental stage are eventually causing the death of the Palb2 (2/2) mouse embryos. Further, establishment of conditional Palb2 mutant mice will help define the precise role and mode of action of Palb2 during organogenesis and tumorigenesis.
MATERIALS AND METHODS
Generation of Palb2 gene trap mice
The gene trap clone CG0691 (Sanger Institute Gene Trap Resource) was injected into C57BL/N6 mouse blastocysts to generate chimeric mice. Breeding of the chimeric mice with C57BL/N6 mice produced HE (Palb2 (+/2) ) offspring carrying the trapped allele. In order to locate the exact integration site of the gene trap insertion, overlapping PCR amplicons compatible with a gene trap-specific 5 ′ reverse primer were designed to cover intron 1 of the Palb2 gene. Primers used for the PCR reaction are indicated in Supplementary Material, Table S1 . Direct sequencing revealed the exact integration site of the gene trap (data not shown). All the studies were carried out in a mixed genetic background (129/C57BL/6N, 1:1). The C57BL/6N mice used as blastocyst donors were obtained from Charles River Laboratories (Willmington, MA, USA). The mice were fed with a Soya-free diet, and they were maintained in a specific pathogen-free stage at the Central Animal Laboratory of the University of Turku. All studies carried out with the mice were approved by the Finnish ethical committee for experimental animals (2008-00142), complying with international guidelines on the care and use of laboratory animals.
Genotype analysis
Genotyping of the mice was performed on DNA, extracted from yolk sacs of E7.5 -E9.5 embryos, or earmarks of 2-week-old mice. Primers (WTs) 5
′ -CTTTTGGGGGA TAGCAGTCA-3 ′ and (WTa) 5 ′ -TTGTTGCTGCTGAGT TCCTG-3 ′ , specific for the targeted intronic sequence, and a primer from the gene trap (GTa) 5
′ -AGTATCGGCCTCA GGAAGATCG-3 ′ were used to detect the WT and the mutant allele, respectively. Primer pair WTs/WTa amplified a 720 bp fragment in both heterozygote and WT DNA samples, whereas the primer pair WTs/GTa amplified a 510 bp fragment in both Palb2 (+/2) and Palb2 (2/2) DNA. The mutant allele was also identified by primers 5 ′ -TTA TCG ATG AGC GTG GTG GTT ATG C-3 ′ and 5 ′ -GCG CGT ACA TCG GGC AAA TAA TAT C-3 ′ that amplified a 680 bp internal segment of the Lac-Z reporter gene. b-Galactosidase staining E7.5 -E9.5 embryos were used to visualize the expression of the fusion gene resulted from the gene trap insertion. The embryos were dissected, washed in PBS and fixed in PBS (pH 7.3) containing 0.2% gluteraldehyde, 2 mM MgCl 2 and 5 mM EDTA for 30 min. Thereafter, the embryos were washed overnight in PBS containing 0.02% NP-40, 2 mM MgCl 2 and 0.01% Na-deoxycholate, and incubated overnight at 378C with b-galactosidase substrate (X-Gal; 1 mg/ml; Fermentas, MD, USA) in washing buffer, supplemented with 5 mM potassium ferrocyanide and 5 mM potassium ferricyanide. The stained embryos were further fixed in 4% paraformaldehyde at room temperature for 20 min, washed with PBS and photographed. Histology E6.5 -E8.5 embryos were isolated in ice-cold PBS, fixed overnight in 4% paraformaldehyde at 48C, dehydrated and embedded in paraffin. Four micrometer thick sections were cut and stained with hematoxylin and eosin.
In situ hybridization
Whole-amount in situ hybridization was performed using DIG-labeled cRNA probes for Lim1, Shh, Brachyury as described by Wilkinson and Green (1990; 34) using InSituPro automate (Intavis, Germany). Samples were photographed with a Leica stereomicroscope equipped with a DC300 camera and the IM1000 software. For histology, fixed wholeamount embryos were embedded in 5% agarose and 10 mm vibratome sections were cut (Leica vibratome), counterstained with eosin, analyzed and photographed with Zeiss Axiophot II microscope with Axiocam and AxioVision 3.1 software.
Blastocyst culture in vitro
Palb2
(+/2) males and females were mated and E3.5 embryos were collected by flushing the uterus of the pregnant females with PBS. Blastocysts were individually cultured in ES cell medium without leukemia inhibitory factor on gelatin of feeder cells (Gibco, Invitrogen, Carlsbad, CA, USA) in 5% CO 2 at 378C. Cultured embryos were followed every 24 h for 7 days and the morphology of the embryos was determined, and the embryos were genotyped by PCR.
Analysis of mRNA expression
Total RNA was isolated from the E8.5 mouse embryos with the RNeasy Mini Kit (Qiagen, Hilden, Germany), and 1 mg of total RNA was treated with DNase I (Invitrogen, Carlsbad, CA, USA). cDNA was synthesized using reverse transcriptase (Finnzymes Oy, Espoo, Finland), and quantitative RT -PCR was performed using the primers for mouse Brca1, Brca2, Rad51, p21, p53, p27 and Palb2. All primers used in qRT -PCR are described in Supplementary Material, Table S2 . Quantitative RT -PCR reactions were carried out using DNA Engine Opticon system TM (MJ Research, MA, USA), and the QuantiTect SYBR Green RT -PCR Kit (Qiagen, CA, USA) with continuous fluorescence detection. All qRT -PCR data were normalized to the expression of mouse Ppia gene.
Statistical methods
The genotypic distribution of the embryos at different age (E7.5-E11.5 and 1d) was analyzed for concordance to the Hardy -Weinberg equilibrium, by using the Pearson's x 2 or Fisher's exact tests. The online Hardy -Weinberg equilibrium test (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl) was used to conduct this assessment. All P-values were two sided. The results of qRT -PCR were analyzed by t-test or Mann -Whitney rank-sum test. Significance was set as P , 0.05 and the values were presented as mean + SD.
